Home
Business model
Pipeline
Partnership
Genome-editing
Possibilities of
Genome editing technology
CRISPR-Cas3
About us
Company Overview/ History
Top Message
Leadership
News
Careers
Contact
JA
EN
MENU
JA
EN
Home
Business model
Pipeline
Partnership
Genome-editing
Possibilities of
Genome editing technology
CRISPR-Cas3
About us
Company Overview/ History
Top Message
Leadership
News
Careers
Privacy policy
Contact us here
Contact Us
2026.04.30
IP
CRISPR-Cas3 Basic Patent Issued in Europe (European Patent No. 3950942)
News
Back to List
